Editorial Board

Editors-in-Chief

José Leopoldo Ferreira Antunes

José Leopoldo Ferreira Antunes is Professor of Epidemiology at the University of São Paulo School of Public Health. His research focuses on oral health, health inequalities, epidemiological methods, and population health. He has made important contributions to understanding how social determinants influence health outcomes and to strengthening evidence-based public health policy.

Marco Aurelio De Anselmo Peres

Marco A. Peres is a dental public health researcher and epidemiologist whose work focuses on oral health inequalities, life-course epidemiology, and chronic disease prevention. His research explores the ways in which social and environmental conditions influence oral and general health throughout life and contributes to efforts to reduce health disparities.

Editorial Board

Abla Mehio Sibai

Líbano

Abla Mehio Sibai is Professor of Epidemiology and Dean of the Faculty of Health Sciences at the American University of Beirut. Her research focuses on aging, chronic disease epidemiology, and health inequities, particularly among populations affected by conflict and social instability. She has published extensively on cardiovascular disease and healthy longevity and has played a leading role in translating research evidence into public health policy and practice across the Middle East. 

Akindele Olupelumi Adebiyi

Nigeria

Akin Adebiyi is a Professor of Epidemiology and Public Health whose research focuses on cardiovascular disease, hypertension, genetics, and population health in Africa. His work seeks to understand the causes and consequences of chronic diseases in African populations and to generate evidence that improves prevention, management, and health outcomes. He has contributed significantly to advancing cardiovascular epidemiology and genetic research in low- and middle-income settings.

Aluísio J. D. Barros

Brazil

Professor Aluísio J. D. Barros is a distinguished epidemiologist specializing in health equity, maternal and child health, and global health monitoring. He earned his medical degree in Brazil (1983) and a PhD from the London School of Hygiene and Tropical Medicine (1996).
Currently a Professor of Epidemiology at Universidade Federal de Pelotas (UFPel), he co-founded and directs the International Center for Equity in Health (ICEH) and leads research for the Pelotas birth cohorts. Since 2009, his work has focused on tracking health inequalities in low- and middle-income countries alongside initiatives like Countdown to 2030, WHO, and UNICEF. His key contributions include perfecting equiplots and developing global health indicators such as SWPER (women’s empowerment) and ANCq (antenatal care quality). He also teaches advanced statistics and mentors postgraduate scholars internationally.

An Pan

China

An Pan is an epidemiologist whose research focuses on cardiometabolic diseases, nutrition, obesity, diabetes, and healthy aging. His work uses large-scale population studies and clinical research to investigate lifestyle and metabolic risk factors and their impact on long-term health. Through his research, he has contributed to a better understanding of how diet and lifestyle influence chronic disease risk and prevention.

Ana Isabel Ribeiro

Portugal

Ashley Felix

USA

Ashley S. Felix is Associate Professor of Epidemiology in the Department of Epidemiology and Prevention at the Wake Forest University School of Medicine. Her research focuses on gynaecologic cancer epidemiology, with particular emphasis on endometrial cancer treatment patterns, access to clinical trials, and multilevel contributors to racial and socioeconomic disparities in cancer outcomes. 

Benjamin W. Chaffee

USA

Benjamin W. Chaffee is Professor of Oral Epidemiology and Dental Public Health at the University of California San Francisco. His research examines the health impacts of tobacco use, oral health across the life course, and disease prevention. His work informs public health policy, tobacco regulation, and clinical practice while advancing understanding of behavioural and environmental influences on health. 

Bernardo Horta

Brazil

Jonathan Huang

Dr. Huang is an epidemiologist and Assistant Professor of Epidemiology and Data Science in the Department of Public Health Sciences at the University of Hawaii at Manoa. His work involves improving methods to better understand intergenerational, social and environmental mechanisms for health and chronic disease, including the development of computational methods leveraging multi-omics to reduce confounding biases in longitudinal, non-experimental cohort studies. 

Brigid M. Lynch

Australia

Brigid M. Lynch PhD is Senior Principal Research Fellow at Cancer Council Victoria and Honorary Professorial Fellow at the University of Melbourne. Her research focuses on cancer epidemiology, modifiable risk factors, molecular and genetic epidemiology, and causal inference. She is a principal investigator of the Australian Breakthrough Cancer Study, a cohort of more than 50,000 adults investigating how genetic, environmental, and behavioural factors influence cancer risk. She currently serves as the Western Pacific Regional Councillor of the International Epidemiological Association and is a Past President and Fellow of the Australasian Epidemiological Association.

Britton Trabert

USA

C Mary Schooling

China

Carme Borrell

Spain

Carme Borrell is a physician (MD) and PhD in public health whose research focuses on social inequalities in health, gender equity, urban health, and the social determinants of health, including housing and health. She has led major public health initiatives and has contributed extensively to research examining how social and economic factors influence health outcomes. Her work has informed policies aimed at reducing inequalities and improving population health.

Camille Raynes-Greenow

Camille Raynes-Greenow is Professor of Epidemiology and a leading maternal and child health researcher. Her work focuses on reproductive, perinatal, and early-life health, with particular expertise in applying epidemiological evidence to improve outcomes for women and children. She has extensive experience translating research findings into policy and practice to strengthen public health programmes and healthcare delivery.

Christina Song Ci

China

Ci Song focuses on the epidemiology and prevention of chronic liver diseases, including chronic hepatitis B, metabolic dysfunction-associated steatotic liver disease, cirrhosis, and hepatocellular carcinoma. Her work draws on big data resources to address clinically and public health relevant questions, with interests in risk prediction, real-world evidence, and the translation of epidemiological evidence into practice. Alongside her research, she is interested in using academic social media to improve the visibility, accessibility, and engagement of epidemiological research.

David M. Evans

Australia

David M. Evans is Professor of Statistical Genetics and Director of the Centre for Population and Disease Genomics at the Institute for Molecular Bioscience (IMB) at the University of Queensland. His research interests include the genetic mapping of complex traits and diseases and the development of statistical methodologies in genetic epidemiology including approaches for gene mapping, causal inference, Mendelian randomization and dissecting the genetic architecture of common complex traits.

David Henry

Australia

David Henry is Honorary/ Adjunct Professor at Bond University, the University of New South Wales and the University of Melbourne, in Australia. He also holds the positions of Professor Emeritus at the Faculty of Medicine, University of Toronto and Emeritus Scientist at the Institute for Clinical Evaluative Sciences (ICES) in Ontario, Canada.

He graduated in medicine at the University of Glasgow, UK and is a Fellow of the Royal College of Physicians of Edinburgh. He specialised in general internal medicine, clinical pharmacology and gastroenterology at the University of Nottingham UK, before moving to Australia as a general physician and professor of clinical pharmacology at the University of Newcastle, NSW. In that role he was involved extensively in the evaluation of medicines for public subsidy in Australia and in the development of the discipline of pharmacoepidemiology.

Subsequently, in Canada he held the position of President and CEO at the Institute for Clinical Evaluative Sciences (ICES) in Toronto and Professor of Health Systems Data at the University of Toronto, Canada.

He has retired from clinical practice and lives on the sub-tropical northeastern coast of New South Wales, where he is a volunteer firefighter.

Haidong Kan

China

Haidong Kan is Professor of Environmental Epidemiology and Associate Dean at Fudan University School of Public Health. His research examines the health effects of air pollution and climate change and their implications for population health. A Fellow of the International Society of Environmental Epidemiology, he is internationally recognised for advancing environmental health research and informing public health responses to environmental risks. 

Ali Khashan

Jennifer Nuzzo

USA

Jennifer B. Nuzzo is Professor of Epidemiology and an internationally recognised expert in global health security, infectious disease epidemiology, and pandemic preparedness. Her work focuses on strengthening health systems' ability to prevent, detect, and respond to emerging biological threats. She is widely known for translating scientific evidence into practical policy recommendations for governments and public health organisations.

Jixuan Ma

China

Jixuan Ma is an epidemiologist whose research focuses on chronic disease epidemiology and population health. His work focuses on environmental and occupational risk factors for chronic diseases and aims to inform effective prevention strategies.

Johannes Textor

The Netherlands

José Manuel Aburto

UK

José Manuel Aburto is Associate Professor of Demography at London School of Hygiene and Tropical Medicine. José Manuel's research specializes in formal demography and the measurement of inequalities in longevity, contributing influential work that has been recognized internationally. Theoretically and methodologically, his work follows two main strands. First, his work develops and advances formal demographic techniques to measure inequalities in the length of life and uses this perspective to generate new ways of analysing population health. Second, through these and other methodological tools, his work examines the structural and social determinants of population health inequalities.

Jun Lv

China

Jun Lv is Professor of Epidemiology whose research focuses on chronic disease epidemiology, nutrition, lifestyle risk factors, and cardiometabolic health. Her work leverages large-scale cohort studies to examine the determinants of major chronic diseases and to generate evidence that supports prevention and informed health policy.

Katy Bell

Australia

Kosuke Inoue

Japan

Kosuke Inoue, MD, PhD, is a Professor in the Department of Health Promotion and Behavioral Sciences at Kyoto University, Graduate School of Medicine. He is a physician-epidemiologist with clinical training in endocrinology and advanced methodological training in epidemiology, particularly causal inference and machine learning. He received his MD from the University of Tokyo in 2013 and his PhD in Epidemiology from the UCLA Fielding School of Public Health in 2021.

His research focuses on cardiometabolic and endocrine epidemiology, using randomized trials, large-scale real-world data, and digital health data to evaluate prevention and treatment strategies for chronic diseases. His work integrates modern causal inference and machine learning methods, including target trial emulation, causal mediation analysis, and estimation of heterogeneous treatment effects, to establish causal mechanisms linking the treatment/exposure to the outcome and to identify individuals most likely to benefit from clinical and public health interventions.

He has published widely in leading medical and epidemiology journals, including BMJ, JAMA, and the International Journal of Epidemiology, and is actively involved in scientific publishing, peer review, and editorial activities. He was selected as one of the MIT Technology Review Innovators Under 35 in Japan in 2023 and received the Society for Epidemiologic Research’s Brian MacMahon Early Career Epidemiologist Award in 2026.

Kristian Filion

Canada

Laith Jamal Abu Raddad

Qatar

Laith J. Abu-Raddad is an epidemiologist and global health researcher whose work focuses on infectious disease epidemiology, mathematical modeling, and public health policy. His research has advanced understanding of the transmission, prevention, and population-level impact of sexually transmitted infections, COVID-19, and other infectious diseases. Through epidemiological modeling and large-scale population studies, he has helped shape evidence-based public health decision-making and disease-control strategies at regional and global levels across diverse settings.

Laura Rosella

Canada

Laura C. Rosella is a Professor of Epidemiology and population health scientist at the University of Toronto, internationally recognized for her research on population health analytics, health inequalities, AI, and health-system transformation. Her work integrates linked population data, epidemiologic methods, and predictive analytics to generate actionable evidence that improves health outcomes, reduces inequities, and strengthens public health and health-care policy and practice. She holds a Tier 1 Canada Research Chair in Population Health Transformation and Analytics and leads national initiatives advancing the development, evaluation, and implementation of AI in public and population health.

Lin Shelly Xu

China

Shelly Lin Xu is an epidemiologist whose research focuses on population health, chronic disease epidemiology, and the application of advanced analytical approaches to improve public health outcomes. Her work contributes to understanding disease risk, informing prevention strategies, and strengthening evidence for effective public health policy.

Michael Cook

UK

Michael B. Cook is Chief Science Officer at Our Future Health, the UK's largest health research programme. Trained in molecular and epidemiological sciences, he previously served as a Senior Investigator at the US National Cancer Institute where his research focused on the causes and outcomes of cancer, particularly gastrointestinal and obesity-related cancers. He now leads the scientific strategy and science team of Our Future Health, a large-scale population health programme designed to accelerate discoveries in disease prevention, earlier detection, and treatment through integrated health, genomic, and biosample data. The programme also supports translational research through participant recontact and recruitment into health research studies and clinical trials. His interests span cancer epidemiology, population health, translational research, and the development of research infrastructure that enables large-scale, data-driven health discovery.

Michael Harhay

USA

Michael O. Harhay is an epidemiologist and biostatistician whose research focuses on kidney disease, transplantation, critical care, and global health. His work applies advanced statistical and epidemiological methods to improve patient outcomes, evaluate healthcare interventions, and support evidence-based clinical decision-making.

Michelle Kelly-Irving

France

Mika Ala-Korpela

Finland

Mika Ala-Korpela is a Professor of Computational Medicine at the Faculty of Medicine, University of Oulu, Finland and a Professor of Bioanalytics and Molecular Epidemiology at the School of Pharmacy, University of Eastern Finland. He is an internationally recognised leader in epidemiology, metabolomics, and data science. His research integrates molecular profiling, genetics, and population health data to better understand cardiovascular and metabolic diseases. His work has helped advance the application of metabolomics in large-scale epidemiological studies and improved understanding of disease mechanisms and risk prediction.

Mohammad A. Mansournia

Iran

Mohammad Talaei

UK

Murthy Mittinty

Australia

Murthy N. Mittinty is an epidemiologist and biostatistician whose interests include chronic disease epidemiology, health services research, causal inference, and innovative statistical methods. His research supports the development of evidence-based healthcare and strengthens the application of advanced analytical approaches in population health research.

Nancy H. L. Leung

China

Nicholas Osborne

Australia

Nicholas J. Osborne is an environmental epidemiologist whose research examines how environmental exposures, climate, and the built environment affect human health. His work provides evidence to support public health action and policy development aimed at reducing environmental risks and improving population wellbeing.

Nicole Warrington

Australia

Onyebuchi Arah

USA

Onyebuchi (“Onyi”) Arah trained as a physician–epidemiologist and is currently a Professor of Epidemiology, an Affiliated Professor of Statistics and Data Science, and the Founding Co-Director of the Practical Causal Inference Lab at the University of California, Los Angeles (UCLA) in the United States. He is also an Honorary Skou Professor at the Department of Public Health, Aarhus University, Denmark. His research areas include causal inference, epidemiological methods, computational population health and social, reproductive, perinatal, paediatric, and clinical epidemiology. His empirical studies span both infectious and chronic non-communicable diseases.

Pedro Curi Hallal

USA

Pedro Curi Hallal is an epidemiologist and global health researcher whose work focuses on physical activity, non-communicable diseases, health surveillance, and population health. He has led influential national and international studies on physical activity and health inequalities and is widely recognised for his contributions to global public health research.

Saman Khalatbari Soltani

Australia

Sheena Sullivan

Australia

Stephen Burgess

UK

Stephen Burgess is a statistician and epidemiologist whose research focuses on the use of genetic variants to understand about modifiable causal mechanisms. He has led efforts to improve the accessibility and reliability of studies using the Mendelian randomization paradigm.

Tania King

Australia

Tania King is an Associate Professor and Deputy Director of the Social Equity Research Centre at RMIT University. She completed her PhD in Social Epidemiology at the University of Melbourne.

              Her research is broadly focused on social and structural determinants of mental health and suicide inequalities. A central focus is understanding the mechanisms through which gender shapes mental health, particularly in relation to paid and unpaid work as gendered exposures. Her research examines how the gendered distribution of employment, caring responsibilities and workplace conditions produces inequalities in mental health across the life-course.

              A quantitative social epidemiologist, her work commonly draws on the large cohort studies and linked administrative data to examine the impact of different social determinants on mental health and suicide risk, and to identify optimal points of intervention.

Tania Maria de Araujo

Brazil

Tânia Maria de Araújo is an epidemiologist and Professor of Epidemiology at Universidade Estadual de Feira de Santana (Brazil), where she coordinates the Center for Epidemiology Studies and the National Observatory on Mental Health and Work. Her research focuses on mental health and work, occupational health, psychosocial work factors, social inequalities in health, gender, and intersectionality. She is Co-Chair of the Work Organization and Psychosocial Factors Committee of the International Commission on Occupational Health (ICOH-WOPS) and has played a leading role in advancing epidemiology and public health research in Brazil.

Tazeen Hasan Jafar

Singapura

Professor Tazeen H. Jafar, MD MPH FASN is globally renowned for her extensive expertise and experience in clinical trials, health systems research, and implementation science. Her work focuses on addressing major health challenges such as hypertension, cardiovascular disease, and chronic kidney disease. She is particularly known for her contributions to risk prediction and the development of community-based interventions to improve health outcomes.

Dr. Jafar is a Professor in the Program in Health Services and Population Health Research at Duke-NUS Medical School, Singapore, and holds multiple key roles: Visiting Consultant in Renal Medicine at Singapore General Hospital, Consultant Nephrologist at Durham VA Healthcare System, and Professor at Duke Global Health Institute, Duke University, Durham, NC, USA.

Professor Jafar went to medical school at the Aga Khan University, Karachi, Pakistan, followed by residency in Medicine-Pediatrics (and dual board certification) from University of Texas Health Science Center at Houston, and fellowship in clinical nephrology (with board certification in Nephrology) and clinical research at Tufts Medical Center, Boston. She also obtained master’s in public health from Harvard University.

Professor Jafar has led impactful global health research on chronic non-communicable diseases for over 25 years, supported by grants from MRC, Wellcome Trust, NIH, and Singapore NMRC. She is the chief principal investigator of the COBRA-BPS trial, a landmark study across 30 rural South Asian villages demonstrating a scalable, community health worker–led approach to blood pressure control with potential to reach nearly one billion people in low- and middle-income countries. She has also led key work on GFR estimation and kidney disease risk prediction in South Asians and is a member of the global CKD Prognosis Consortium. She is also a practising nephrologist.

Tony Blakely

Australia

Tony Blakely is a public health physician and epidemiologist. He is committed to answering questions about which public health interventions will achieve the greatest improvements in health and social outcomes, reduce inequalities in health, and do so cost-effectively. His research covers a range of topic areas, intersected with methodological advancements. Whilst principally an epidemiologist, he uses and combines methods from multiple disciplines: biostatistics, economics, econometrics, and computer and data science.
Tony leads the Scalable Health Intervention Evaluation program (SHINE), which is a data science and simulation platform leveraging burden of disease data and methods to rapidly estimate health, health inequality, cost and productivity impacts of virtually any preventive intervention, in any country. 
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Please sign in to your personal account to gift article access.

Gift article access

Please create a link below to share with others. This will provide temporary access to this restricted article.

The link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

The link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses.

You have reached the limit of 10 links within a 30 day period